1 -onset posttreatment manifestations (such as persistent hepatitis) are not uncommon.

2                                      01) and persistent hepatitis B infection (chi2=6.25, 1 df, P=.01

3 nts had evidence of ongoing viral infection: persistent hepatitis B surface antigen in three (6%), HC

4                                              Persistent hepatitis B virus (HBV) infection is characte

5                                              Persistent hepatitis B virus (HBV) infection is establis

6 y-five liver transplantation recipients with persistent hepatitis C viremia by polymerase chain react

7 The virological and cellular consequences of persistent hepatitis C virus (HCV) infection have been e

8 orphisms in HAVCR1 that were associated with persistent hepatitis C virus (HCV) infection in individu

9                                              Persistent hepatitis C virus (HCV) infection is a major

10                                              Persistent hepatitis C virus (HCV) infection is a primar

11                                              Persistent hepatitis C virus (HCV) infection leads to ch

12                                 A stable and persistent Hepatitis C virus (HCV) replication cell cult

13                                              Persistent hepatitis C virus infection is associated wit

14 Chronic infection generally produced a mild, persistent hepatitis characterized by light lymphocytic

15                                              Persistent hepatitis E virus (HEV) infection is describe

16 sy specimen showed chronic active or chronic persistent hepatitis in 11 children, cirrhosis in 1 chil

17 terize the prevalence and pathophysiology of persistent hepatitis in transplanted SCID patients (SCID

18                    Eleven patients developed persistent hepatitis (median of 6 years after HSCT or GT

19 ll patients were discharged, though >50% had persistent hepatitis up to 1 month after discharge.